[go: up one dir, main page]

TR199501082A2 - Farmasötik formülasyonlar. - Google Patents

Farmasötik formülasyonlar.

Info

Publication number
TR199501082A2
TR199501082A2 TR95/01082A TR9501082A TR199501082A2 TR 199501082 A2 TR199501082 A2 TR 199501082A2 TR 95/01082 A TR95/01082 A TR 95/01082A TR 9501082 A TR9501082 A TR 9501082A TR 199501082 A2 TR199501082 A2 TR 199501082A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
TR95/01082A
Other languages
English (en)
Inventor
Patrick John Crowley
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR199501082A2 publication Critical patent/TR199501082A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR95/01082A 1994-09-03 1995-08-31 Farmasötik formülasyonlar. TR199501082A2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
TR199501082A2 true TR199501082A2 (tr) 1996-06-21

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01082A TR199501082A2 (tr) 1994-09-03 1995-08-31 Farmasötik formülasyonlar.

Country Status (8)

Country Link
EP (1) EP0782443A1 (tr)
JP (1) JPH10505595A (tr)
AU (1) AU3471995A (tr)
DZ (1) DZ1926A1 (tr)
IL (1) IL115125A0 (tr)
MA (1) MA23663A1 (tr)
TR (1) TR199501082A2 (tr)
WO (1) WO1996007408A1 (tr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL325411A1 (en) 1995-09-07 1998-07-20 Smithkline Beecham Corp Pharmaceutic preparation
EA002595B1 (ru) * 1997-02-14 2002-06-27 Смитклайн Бичем Лаборатуар Фармасетик Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
DE69922202T2 (de) * 1998-07-06 2005-12-01 Nanobac Oy Verfahren zur beseitigung von nanobakterien
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2011152806A1 (en) * 2010-06-03 2011-12-08 Mahmut Bilgic Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002312B1 (en) * 1977-11-26 1982-02-03 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP1034784A3 (en) * 1993-01-22 2001-06-27 Smithkline Beecham Plc Pharmaceutical formulations containing clavulanic acid and an antibacterial agent

Also Published As

Publication number Publication date
WO1996007408A1 (en) 1996-03-14
AU3471995A (en) 1996-03-27
JPH10505595A (ja) 1998-06-02
IL115125A0 (en) 1995-12-31
MA23663A1 (fr) 1996-04-01
EP0782443A1 (en) 1997-07-09
DZ1926A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
TR199901077A3 (tr) Ispençiyari formülasyonlar.
FI20071025L (fi) Farmaseuttisia koostumuksia
DE69530325D1 (de) Aerosol-arzneiformulierungen
FI971279L (fi) Lääkkeitä
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
DZ2026A1 (fr) Compositions vaccinantes.
DZ2055A1 (fr) Compositions vaccinantes.
DZ1835A1 (fr) Nouvelles formulations.
TR199501082A2 (tr) Farmasötik formülasyonlar.
ID16781A (id) Formulasi-formulasi farmasi
BR9507768A (pt) Composição farmacêutica
ITMI941169A0 (it) Formulazioni farmaceutiche
EP0837863A4 (en) DISODIUM ALENDRONATE PREPARATIONS
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI951155L (fi) Farmaseuttinen valmiste
TR199601018A1 (tr) Farmasötik bilesikler.
FI962738L (fi) Farmaseuttiset koostumukset
FI954050L (fi) Lääkekoostumuksia
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
TR199500776A2 (tr) Farmasötik bilesimler.
SE9404467D0 (sv) Drug formulations
SE9502453D0 (sv) Drug formulations
ZA957349B (en) Pharmaceutical formulations.